A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation

A.M.C. Dingemans, W.W. Mellema, H.J.M. Groen, A.W. van Wijk, S.A. Burgers, P.W. Kunst, E. Thunnissen, D.A.M. Heideman, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)743-751
JournalClinical Cancer Research
Volume19
Issue number3
DOIs
Publication statusPublished - 2013

Cite this

@article{e7ff5caaea2a431bb2b3bcc51928e051,
title = "A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation",
author = "A.M.C. Dingemans and W.W. Mellema and H.J.M. Groen and {van Wijk}, A.W. and S.A. Burgers and P.W. Kunst and E. Thunnissen and D.A.M. Heideman and E.F. Smit",
year = "2013",
doi = "10.1158/1078-0432.CCR-12-1779",
language = "Undefined/Unknown",
volume = "19",
pages = "743--751",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation. / Dingemans, A.M.C.; Mellema, W.W.; Groen, H.J.M.; van Wijk, A.W.; Burgers, S.A.; Kunst, P.W.; Thunnissen, E.; Heideman, D.A.M.; Smit, E.F.

In: Clinical Cancer Research, Vol. 19, No. 3, 2013, p. 743-751.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation

AU - Dingemans, A.M.C.

AU - Mellema, W.W.

AU - Groen, H.J.M.

AU - van Wijk, A.W.

AU - Burgers, S.A.

AU - Kunst, P.W.

AU - Thunnissen, E.

AU - Heideman, D.A.M.

AU - Smit, E.F.

PY - 2013

Y1 - 2013

U2 - 10.1158/1078-0432.CCR-12-1779

DO - 10.1158/1078-0432.CCR-12-1779

M3 - Article

VL - 19

SP - 743

EP - 751

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 3

ER -